These studies suggested that the upregulation of MMP-9 by proinflammatory mediators in brain cells may be a crucial effect upon brain injury and BBB damage that may provide a therapeutic strategy to brain inflammation and neurodegenerative diseases. The gene discussed is MMP9; the disease is neurodegenerative disease.